Last reviewed 2026-04-20 · How we verify

Dove Mild Cleanser

University of Michigan · Phase 1 active Small molecule Quality 0/100

Dove Mild Cleanser is a Small molecule drug developed by University of Michigan. It is currently in Phase 1 development. Also known as: Dove Non-foaming Cleanser.

Likelihood of approval

9.6% vs 9.6% industry baseline

If approved by FDA: likely 2033–2036

Steps remaining: Phase 2 → Phase 3 → NDA/BLA submission

Confidence: Medium

Why this estimate

Baseline phase 1 → approval rate +9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).

Predicted approval windows by jurisdiction (conditional on FDA approval)

Regulator	Country	Likely year	Lag vs FDA
FDA	US	2033–2036	—
EMA	EU	2034–2037	+0.7 yr
MHRA	GB	2034–2037	+0.7 yr
Health Canada	CA	2034–2038	+0.9 yr
TGA	AU	2034–2038	+1.2 yr
PMDA	JP	2034–2038	+1.5 yr
NMPA	CN	2035–2039	+2.3 yr
MFDS	KR	2034–2038	+1.4 yr
CDSCO	IN	2034–2039	+1.8 yr
ANVISA	BR	2035–2039	+2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic name	Dove Mild Cleanser
Also known as	Dove Non-foaming Cleanser
Sponsor	University of Michigan
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Dove Mild Cleanser CI brief — competitive landscape report
Dove Mild Cleanser updates RSS · CI watch RSS
University of Michigan portfolio CI

Frequently asked questions about Dove Mild Cleanser

What is Dove Mild Cleanser?

Dove Mild Cleanser is a Small molecule drug developed by University of Michigan.

Who makes Dove Mild Cleanser?

Dove Mild Cleanser is developed by University of Michigan (see full University of Michigan pipeline at /company/university-of-michigan).

Is Dove Mild Cleanser also known as anything else?

Dove Mild Cleanser is also known as Dove Non-foaming Cleanser.

What development phase is Dove Mild Cleanser in?

Dove Mild Cleanser is in Phase 1.

Manufacturer: University of Michigan — full pipeline
Also known as: Dove Non-foaming Cleanser

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing